In this application we propose to study the phosphoregulatory mechanism and specificity of the MAP kinase ERK2 using single crystal x-ray analysis. Protein kinases are essential molecules in both initiation of signal transduction and in the regulation and integration of cellular processes. The MAP kinase ERK2 has been widely studied as a growth-factor activated, tyrosine phosphorylated enzyme of 41 kDa. This enzyme is activated by a remarkable variety of hormones in differentiated cells and growth factors in dividing cells, indicating that it is a pleiotropic regulatory enzyme. Of proteins in the kinase superfamily, ERK2 is an especially appropriate target for crystallographic studies. ERK2 has a complex and interesting mechanism of regulation that involves obligate dual phosphorylations, on a single tyrosine and a single threonine residue. It lacks associated regulatory proteins, so that through the study of the single polypeptide the regulatory mechanism can be understood. We have crystallized ERK2 in its inactive unphosphorylated conformation and have refined the structure at 2.3 Angstroms resolution. By comparing the structure of the unphosphorylated enzyme with the active conformation of PKA (cAMP-dependent protein kinase) and by mutational analysis, it has been possible to propose a partial model for the phosphoregulation of ERK2. This model will be tested with crystallographic studies of mutant ERK2 molecules in their dephosphorylated states. Doubly phosphorylated and singly phosphorylated forms have been or will be obtained through the action of bacterially expressed MEK (MAP kinase/ERK kinase). These phosphorylated enzymes will be studied crystallographically to elucidate the structural basis for the complex phosphoregulation of ERK2.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK046993-01A1
Application #
2146316
Study Section
Biophysical Chemistry Study Section (BBCB)
Project Start
1994-05-01
Project End
1997-04-30
Budget Start
1994-05-01
Budget End
1995-04-30
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Biochemistry
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Taylor 4th, Clinton A; Juang, Yu-Chi; Earnest, Svetlana et al. (2015) Domain-Swapping Switch Point in Ste20 Protein Kinase SPAK. Biochemistry 54:5063-71
Piala, Alexander T; Humphreys, John M; Goldsmith, Elizabeth J (2014) MAP kinase modules: the excursion model and the steps that count. Biophys J 107:2006-15
Humphreys, John M; Piala, Alexander T; Akella, Radha et al. (2013) Precisely ordered phosphorylation reactions in the p38 mitogen-activated protein (MAP) kinase cascade. J Biol Chem 288:23322-30
Akella, Radha; Min, Xiaoshan; Wu, Qiong et al. (2010) The third conformation of p38? MAP kinase observed in phosphorylated p38? and in solution. Structure 18:1571-8
Lee, Seung-Jae; Cobb, Melanie H; Goldsmith, Elizabeth J (2009) Crystal structure of domain-swapped STE20 OSR1 kinase domain. Protein Sci 18:304-13
Min, Xiaoshan; Akella, Radha; He, Haixia et al. (2009) The structure of the MAP2K MEK6 reveals an autoinhibitory dimer. Structure 17:96-104
Akella, Radha; Moon, Thomas M; Goldsmith, Elizabeth J (2008) Unique MAP Kinase binding sites. Biochim Biophys Acta 1784:48-55
Goldsmith, Elizabeth J; Akella, Radha; Min, Xiaoshan et al. (2007) Substrate and docking interactions in serine/threonine protein kinases. Chem Rev 107:5065-81
Wilsbacher, Julie L; Juang, Yu-Chi; Khokhlatchev, Andrei V et al. (2006) Characterization of mitogen-activated protein kinase (MAPK) dimers. Biochemistry 45:13175-82
Zhou, Tian-Jun; Sun, Li-Guang; Gao, Yan et al. (2006) Crystal structure of the MAP3K TAO2 kinase domain bound by an inhibitor staurosporine. Acta Biochim Biophys Sin (Shanghai) 38:385-92

Showing the most recent 10 out of 22 publications